Pure Global

HYBRIBIO Alpha Thalassemia Genoarray Diagnostic Kit - Indonesia BPOM Medical Device Registration

HYBRIBIO Alpha Thalassemia Genoarray Diagnostic Kit is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207220036. The device is manufactured by GUANGZHOU HYBRIBIO MEDICINE TECHNOLOGY LTD MELALUI HYBRIBIO LIMITED from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. BESTARI SUKSES MAKMUR.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
HYBRIBIO Alpha Thalassemia Genoarray Diagnostic Kit
Analysis ID: AKL 20207220036

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. BESTARI SUKSES MAKMUR

AR Address

KOKAN PERMATA KELAPA GADING LT. 3, BLOK E-5, JL. BOULEVARD GADING RAYA, KELAPA GADING BARAT, KELAPA GADING, JAKARTA UTARA

Registration Date

Aug 28, 2023

Expiry Date

Jan 01, 2026

Product Type

Haematology Package and Kit

Hemoglobin A[bdi2] assay.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing